Compare BridgeBio Pharma Inc (BBIO) vs Union Pacific Corporation (UNP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BridgeBio Pharma Inc vs Union Pacific Corporation — how do they compare? BridgeBio Pharma Inc trades at $83.9 (market cap $16.36B), while Union Pacific Corporation trades at $291.52 (market cap $173.99B). The key difference: Union Pacific Corporation is far larger — about 10.6× BridgeBio Pharma Inc's market cap, and Union Pacific Corporation pays a 1.94% dividend while BridgeBio Pharma Inc pays none. Which is the better fit depends on your goals.
| BBIO | UNP | |
|---|---|---|
Market Cap | $16.36B | $173.99B |
Sector | Health | Industrials |
52-Week High | $90.17 | $307.32 |
52-Week Low | $47.29 | $214.91 |
Enterprise Value | $18.14B | $203.04B |
Dividend Yield | — | 1.94% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BridgeBio Pharma Inc
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.
Read more on BBIO →About Union Pacific Corporation
Omaha, Nebraska-based Union Pacific is the largest public railroad in North America. Operating on more than 30,000 miles of track in the western two thirds of the U.S., UP generated roughly $22 billion of revenue in 2021 by hauling coal, industrial products, intermodal containers, agriculture goods, chemicals, and automotive goods. UP owns about one fourth of Mexican railroad Ferromex and derives about 10% of its revenue hauling freight to and from Mexico.
Read more on UNP →
